By Editor , 1 November 2026
Profound Medical Adds Cook Medical Channel for U.S. TULSA-PRO Sales

TORONTO – October 31, 2026 -- Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) has signed a supply and distribution agreement with the iMRI Division of Cook Medical, adding a second U.S. capital equipment channel for its TULSA-PRO system while keeping recurring treatment kit and service revenue in-house.

By Editor , 16 October 2026
Cancer Diagnostics Market to Reach $41.5B by 2031 on AI, Genomics

Sheridan – October 15, 2026 -- The global cancer diagnostics market is valued at USD 29.3 billion in 2026 and is projected to reach USD 41.5 billion by 2031, a CAGR of 7.2%, according to a new study by Wissen Research.

Demand starts with patient volume. The International Agency for Research on Cancer counted about 20 million new cancer cases and 9.7 million cancer deaths worldwide in 2022, and expects annual new cases to pass 35 million by 2050. Each patient may need screening, diagnosis, staging, molecular characterization and follow-up.

By Editor , 5 October 2026
IVD Quality Control Market to Hit $2.2B by 2031 as Labs Go Digital

Sheridan, Wyo. – October 05, 2026 -- The global in vitro diagnostics (IVD) quality control market is set to climb from $1.7 billion in 2026 to $2.2 billion by 2031, a 5.3% compound annual growth rate, according to a new study by Wissen Research.